Brickell Biotech, Inc. Made Headway

Mon 15 Jun 20 at 05:30 PM
Brickell Biotech, Inc. Made Headway

Brickell Biotech, Inc. (BBI:NASDAQ) rocketted at $1.89, representing a gain of 50%. The stock got featured on our News Catalysts scanner on Mon 15 Jun 20 at 08:08 AM in the 'BIOTECH' category. From Fri 29 May 20, the stock recorded 50.00% Up Days and 45.45% Green Days

The stock spiked on Wed 10 Jun 20 at $1.59 with a volume of 1M+.

About Brickell Biotech, Inc. (BBI:NASDAQ)

Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000 and BBI-6000 among others.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.